Koukoulas, K.; Lygoura, V.; Kartalidis, P.; Gatselis, N.K.; Petinaki, E.; Dalekos, G.N.; Simos, G.
Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study. Diagnostics 2022, 12, 1404.
https://doi.org/10.3390/diagnostics12061404
AMA Style
Koukoulas K, Lygoura V, Kartalidis P, Gatselis NK, Petinaki E, Dalekos GN, Simos G.
Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study. Diagnostics. 2022; 12(6):1404.
https://doi.org/10.3390/diagnostics12061404
Chicago/Turabian Style
Koukoulas, Kreon, Vasiliki Lygoura, Philip Kartalidis, Nikolaos K. Gatselis, Efthymia Petinaki, George N. Dalekos, and George Simos.
2022. "Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study" Diagnostics 12, no. 6: 1404.
https://doi.org/10.3390/diagnostics12061404
APA Style
Koukoulas, K., Lygoura, V., Kartalidis, P., Gatselis, N. K., Petinaki, E., Dalekos, G. N., & Simos, G.
(2022). Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study. Diagnostics, 12(6), 1404.
https://doi.org/10.3390/diagnostics12061404
